Birch Biomed Inc
Clinical trials sponsored by Birch Biomed Inc, explained in plain language.
Birch Biomed Inc
BRBM
NASDAQ
Biotech company developing cancer therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cream aims to tame burn scars – trial underway Results expected Oct 2026 (estimated)